On Friday, Shares of Kite Pharma Inc (NASDAQ: KITE ), added 0.11% and closed at $55.72 in the last trading session. The last trading range of the stock ranges between $55.14 and $57.65. The company’s Market capitalization is $2.77 Billion with the total Outstanding Shares of 49.60 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $38.41 and reached to max level of $89.84. Kite Pharma, Inc. (KITE) recently declared updated results from the Phase 1 portion of Kite’s ZUMA-1 clinical trial of its lead product candidate, KTE-C19, in patients with chemorefractory, aggressive non-Hodgkin lymphoma (NHL). The results were offered in an oral presentation at the European Society for Medical Oncology (ESMO) annual congress. KTE-C19 is an investigational therapy in which a patient’s T cells are genetically modified to express a chimeric antigen receptor (CAR) that is designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias.
“These data complement our recently stated interim topline results from ZUMA-1 Phase 2 and support the potential for KTE-C19 to be a breakthrough therapy for chemorefractory, aggressive NHL,” said David Chang, M.D., Ph.D., Executive Vice President, Research and Development, and Chief Medical Officer of Kite. “We are encouraged that the complete remission rate of 43 percent in the Phase 1 portion of the study continues through month 12 and look forward to reporting additional data on the durability of response to KTE-C19 from the Phase 2 portion of ZUMA-1 in 2017.”
Shares of Cerner Corporation (NASDAQ:CERN), added 0.44% and closed at $61.13 in the last trading session. The last trading range of the stock ranges between $60.57 and $61.23. The company’s Market capitalization is $20.74 Billion with the total Outstanding Shares of 337.71Billion. During the 52-week trading session the minimum price at which share price traded, registered at $49.59 and reached to max level of $68.31. Miami Children’s Health System (MCHS) and its associates, Pediatric Specialists of America and Nicklaus Children’s Hospital, have expanded their relationship with Cerner, a global leader in health care technology. Through its Business Office Services (BOS) offering, Cerner will manage professional revenue cycle administration across the health system’s 200-member employed physician group practice.
In conjunction with the existing systemwide Cerner Millennium® electronic health record (EHR) and billing platforms, BOS is designed to facilitate Pediatric Specialists of America to create operational efficiencies and improve financial communication with patients.
“Our long-term engagement with Cerner has already assisted our health system achieve multiple clinical and financial aims, and we are optimistic about expanding our relationship,” said Edward Martinez, senior vice president and CIO, Miami Children’s Health System. “When it was time to re-evaluate our ambulatory revenue cycle processes, we believe that Cerner Business Office Services can assist us achieve success among our growing pediatric provider community.”